OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 03, 2021
Advanced manufacturing technologies are available, but challenges need to be addressed.
February 02, 2021
Collaboration between equipment suppliers and users is leading to innovation and optimization in biopharmaceutical manufacturing.
January 28, 2021
The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A platform.
January 05, 2021
The new facility, to be located in Boston, MA, will contain experimental and analytical equipment for viral vector and advanced therapy process development and will expand the CDMO’s manufacturing capacity.
December 01, 2020
A holistic approach to validation and quality assurance is essential.
November 03, 2020
As biopharmaceutical process development advances, a more collaborative and knowledge-based approach, driven by better analytics and high-throughput system integration, is reducing the risk of failure.
October 29, 2020
Two FDA-funded projects at RCPE will look at real-time monitoring and control of drug tablet coating and developing a digital twin for drug production control.
September 02, 2020
Dimethyl sulfoxide is increasingly used in high-risk parenteral and medical device applications that must be manufactured as sterile products in their finished form. A study evaluated the effects four sterilization techniques have on the product quality of this ingredient.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 03, 2020
This study suggests that using a simple centrifugal method can produce a natural polymer-blend molecule that can successfully be used as an oral delivery mechanism for poorly soluble drugs.
July 31, 2020
The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.
June 30, 2020
The company now offers its CONFIDENCE virus clearance services to support validation of viral clearance processes.
May 20, 2020
This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.
May 15, 2020
Ensuring the quality of data in process monitoring and control systems starts in process development phases.
May 02, 2020
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
Bioprocessing advances improve product yield, cut costs, and streamline integration between upstream and downstream processes.
April 22, 2020
Analyzing process and equipment data provides insights that can improve quality and productivity of pharmaceutical manufacturing.
April 16, 2020
The technology center is dedicated to developing greener, safer chemistries for manufacturing pharmaceutical raw materials and intermediates.
April 01, 2020
The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.
March 02, 2020
Tackling process development early on can better optimize manufacturing processes for emerging therapies.